Abstract |
In order to assess if the anabolic action of PTH is related to changes in circulating levels of insulin-like growth factor-I and -II ( IGF-I and -II), and IGF binding protein 3 (IGFBP-3), 24 h of PTH infusion was performed in healthy women and in patients with rheumatoid arthritis (RA), a state where both bone metabolism and PTH secretion is influenced by the inflammatory activity. The patients with RA had lower basal levels of both IGF-I and -II than the healthy controls (P < 0.05). In neither group did the IGFs change after 24 h of PTH administration, while IGFBP-3 was significantly increased in the healthy controls (4600 +/- 1200 to 5750 +/- 2200 micrograms/l, P < 0.05). IGFBP-3 was not affected by PTH infusion in patients with RA when the disease had high activity, but when inflammation had subsided they responded with a similar increase in IGFBP-3 as the control group and basal IGF-I and -II levels were normalised. Since IGFBP-3 can enhance the anabolic action of IGF-I, increased IGFBP-3 levels after PTH infusion may reflect a mechanism by which PTH is anabolic for bone. Inflammation may inhibit bone formation via decreased serum levels of IGFs and blocked IGFBP-3 response to PTH.
|
Authors | A G Johansson, D J Baylink, E af Ekenstam, E Lindh, S Mohan, S Ljunghall |
Journal | Bone and mineral
(Bone Miner)
Vol. 24
Issue 1
Pg. 25-31
(Jan 1994)
ISSN: 0169-6009 [Print] Ireland |
PMID | 7514466
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Carrier Proteins
- Insulin-Like Growth Factor Binding Proteins
- Parathyroid Hormone
- Peptide Fragments
- parathyroid hormone (1-38)
- Insulin-Like Growth Factor I
- Insulin-Like Growth Factor II
- Calcium
|
Topics |
- Adult
- Aged
- Arthritis, Rheumatoid
(blood)
- Bone and Bones
(drug effects, metabolism)
- Calcium
(blood)
- Carrier Proteins
(blood)
- Female
- Humans
- Infusion Pumps
- Insulin-Like Growth Factor Binding Proteins
- Insulin-Like Growth Factor I
(metabolism)
- Insulin-Like Growth Factor II
(metabolism)
- Male
- Middle Aged
- Parathyroid Hormone
(administration & dosage, pharmacology)
- Peptide Fragments
(administration & dosage, pharmacology)
|